276 related articles for article (PubMed ID: 19924236)
1. Regulatory function of a novel population of mouse autoantigen-specific Foxp3 regulatory T cells depends on IFN-gamma, NO, and contact with target cells.
Chen C; Liu CP
PLoS One; 2009 Nov; 4(11):e7863. PubMed ID: 19924236
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis.
Feng T; Cao AT; Weaver CT; Elson CO; Cong Y
Gastroenterology; 2011 Jun; 140(7):2031-43. PubMed ID: 21419767
[TBL] [Abstract][Full Text] [Related]
3. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.
Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I
J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903
[TBL] [Abstract][Full Text] [Related]
4. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
6. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
7. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
Chen C; Lee WH; Yun P; Snow P; Liu CP
J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
[TBL] [Abstract][Full Text] [Related]
8. Novel CD8+ Treg suppress EAE by TGF-beta- and IFN-gamma-dependent mechanisms.
Chen ML; Yan BS; Kozoriz D; Weiner HL
Eur J Immunol; 2009 Dec; 39(12):3423-35. PubMed ID: 19768696
[TBL] [Abstract][Full Text] [Related]
9. DC expressing transgene Foxp3 are regulatory APC.
Lipscomb MW; Taylor JL; Goldbach CJ; Watkins SC; Wesa AK; Storkus WJ
Eur J Immunol; 2010 Feb; 40(2):480-93. PubMed ID: 19941313
[TBL] [Abstract][Full Text] [Related]
10. Foxp3-expressing CD4(+)T cells under the control of INF-gamma promoter prevent diabetes in NOD mice.
Wang R; Han G; Wang J; Song L; Chen G; Xu R; Yu M; Qian J; Shen B; Li Y
Mol Ther; 2007 Aug; 15(8):1551-7. PubMed ID: 17534268
[TBL] [Abstract][Full Text] [Related]
11. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation.
Onishi Y; Fehervari Z; Yamaguchi T; Sakaguchi S
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10113-8. PubMed ID: 18635688
[TBL] [Abstract][Full Text] [Related]
12. Foxp3+ Treg expanded from patients with established diabetes reduce Helios expression while retaining normal function compared to healthy individuals.
Du W; Shen YW; Lee WH; Wang D; Paz S; Kandeel F; Liu CP
PLoS One; 2013; 8(2):e56209. PubMed ID: 23409157
[TBL] [Abstract][Full Text] [Related]
13. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP
Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738
[TBL] [Abstract][Full Text] [Related]
14. Decreased suppression of CD8
Giri PS; Dwivedi M; Begum R
Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T cells can mediate their function through the stimulation of APCs to produce immunosuppressive nitric oxide.
Chen C; Lee WH; Zhong L; Liu CP
J Immunol; 2006 Mar; 176(6):3449-60. PubMed ID: 16517713
[TBL] [Abstract][Full Text] [Related]
16. MHC class II expression identifies functionally distinct human regulatory T cells.
Baecher-Allan C; Wolf E; Hafler DA
J Immunol; 2006 Apr; 176(8):4622-31. PubMed ID: 16585553
[TBL] [Abstract][Full Text] [Related]
17. CD4+CD25+Foxp3+IFN-γ+ human induced T regulatory cells are induced by interferon-γ and suppress alloresponses nonspecifically.
Daniel V; Sadeghi M; Wang H; Opelz G
Hum Immunol; 2011 Sep; 72(9):699-707. PubMed ID: 21664396
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
19. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
[TBL] [Abstract][Full Text] [Related]
20. Isolation and enrichment of mouse insulin-specific CD4
Đedović N; Paunović V; Stojanović I
J Immunol Methods; 2019 Jul; 470():46-54. PubMed ID: 31039339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]